Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today?

Medicinal Research Reviews
Chandra B MishraClaudiu T Supuran

Abstract

Carbonic anhydrases (CAs, EC 4.2.1.1) are widely distributed metalloenzymes in both prokaryotes and eukaryotes. They efficiently catalyze the reversible hydration of carbon dioxide to bicarbonate and H+  ions and play a crucial role in regulating many physiological processes. CAs are well-studied drug target for various disorders such as glaucoma, epilepsy, sleep apnea, and high altitude sickness. In the past decades, a large category of diverse families of CA inhibitors (CAIs) have been developed and many of them showed effective inhibition toward specific isoforms, and effectiveness in pathological conditions in preclinical and clinical settings. The discovery of isoform-selective CAIs in the last decade led to diminished side effects associated with off-target isoforms inhibition. The many new classes of such compounds will be discussed in the review, together with strategies for their development. Pharmacological advances of the newly emerged CAIs in diseases not usually associated with CA inhibition (neuropathic pain, arthritis, cerebral ischemia, and cancer) will also be discussed.

References

May 1, 1977·Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology·H Kazemi, L Choma
Oct 1, 1992·International Journal of Sports Medicine·A R BradwellC Imray
Aug 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·C M TangM Morad
Dec 11, 1991·Respiration Physiology·E R SwensonP H Hackett
Jan 1, 1986·Acta Physiologica Scandinavica·G LönnerholmE Bárány
Oct 1, 1987·The Tohoku Journal of Experimental Medicine·T IgariT Shimamura
Oct 1, 1967·Physiological Reviews·T H Maren
Nov 21, 1995·Proceedings of the National Academy of Sciences of the United States of America·P A Boriack-SjodinD W Christianson
Aug 15, 1995·The Biochemical Journal·C J LynchK F Lanoue
Apr 29, 1993·The New England Journal of Medicine·T YoungS Badr
Apr 16, 1993·Brain Research. Developmental Brain Research·L VelíŝekW Cammer
Mar 1, 1996·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S A HazenC J Lynch
May 1, 1996·The Annals of Pharmacotherapy·W G Reiss, K S Oles
Dec 1, 1996·Progress in Lipid Research·J B Allred, K E Reilly
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·O TüreciW S Sly
Oct 15, 1998·Proceedings of the National Academy of Sciences of the United States of America·S V IvanovM I Lerman
Jun 9, 1999·The American Journal of Psychiatry·A Gordon, L H Price
Jun 15, 1999·Epilepsia·A WilnerR Pollard
Nov 7, 1999·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·F BrigantiC T Supuran
Dec 30, 1999·Progress in Retinal and Eye Research·M F Sugrue
Feb 11, 2000·Il Farmaco·E E ChufánL Bruno-Blanch
May 23, 2000·Critical Reviews in Biochemistry and Molecular Biology·G L Semenza
Sep 9, 2000·FEMS Microbiology Reviews·K S Smith, J G Ferry
Dec 2, 2000·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·S ParkkilaH Rajaniemi
Jan 12, 2001·The European Respiratory Journal·L GroteH Kraiczi
Mar 10, 2001·The American Journal of Pathology·S IvanovE J Stanbridge
Aug 9, 2001·Proceedings of the National Academy of Sciences of the United States of America·D A WhittingtonD W Christianson
Aug 23, 2001·Trends in Molecular Medicine·G L Semenza
Jan 11, 2002·Journal of Medicinal Chemistry·Bernard MasereelClaudiu T Supuran
Dec 25, 2002·Medicinal Research Reviews·Claudiu T SupuranAngela Casini
Feb 8, 2003·Science·James O HillJohn C Peters
Feb 8, 2003·Science·Jeffrey M Friedman
Apr 3, 2003·British Journal of Cancer·P H WatsonA L Harris

❮ Previous
Next ❯

Citations

Oct 18, 2020·Metabolites·Andrea AngeliClaudiu T Supuran
Sep 26, 2020·Journal of Enzyme Inhibition and Medicinal Chemistry·Linda J UrbanskiSeppo Parkkila
Nov 29, 2020·Expert Opinion on Therapeutic Patents·Clemente CapassoClaudiu T Supuran
Dec 22, 2020·Journal of Biomolecular Structure & Dynamics·Avinash KumarSuvarna G Kini
Dec 29, 2020·Journal of Enzyme Inhibition and Medicinal Chemistry·Linda J UrbańskiClaudiu T Supuran
Dec 29, 2020·Journal of Experimental Pharmacology·Claudiu T Supuran
Feb 20, 2021·Journal of Enzyme Inhibition and Medicinal Chemistry·Rita MeledduSimona Distinto
Feb 23, 2021·Journal of Enzyme Inhibition and Medicinal Chemistry·Alessio NocentiniClaudiu T Supuran
Dec 31, 2020·Chemistry : a European Journal·Jie JianJasmin Mecinović
Mar 10, 2021·Expert Opinion on Therapeutic Patents·Claudiu T Supuran
Apr 29, 2021·Expert Opinion on Therapeutic Patents·Alessio NocentiniClaudiu T Supuran
Apr 30, 2021·Expert Opinion on Drug Discovery·Francesco MincioneClaudiu T Supuran
May 21, 2021·Clinical Science·Claudiu T Supuran
May 4, 2021·Chembiochem : a European Journal of Chemical Biology·Michael KuglerBohumír Grüner
Jun 1, 2021·Journal of Enzyme Inhibition and Medicinal Chemistry·Ilaria DettoriFelicita Pedata
Jun 3, 2021·Journal of Enzyme Inhibition and Medicinal Chemistry·Secil DenizOzen Ozensoy Guler
Jun 3, 2021·International Journal of Molecular Sciences·Zuo-Peng ZhangMao-Sheng Cheng
Jun 3, 2021·International Journal of Molecular Sciences·Irene BulliFelicita Pedata
Jun 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Sarah L MuellerSally-Ann Poulsen
Jul 31, 2021·Journal of Enzyme Inhibition and Medicinal Chemistry·Claudiu T Supuran
Sep 10, 2021·Future Medicinal Chemistry·Claudiu T Supuran

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Opinion on Therapeutic Patents
Mayank AggarwalRobert McKenna
Journal of Enzyme Inhibition and Medicinal Chemistry
Doretta CuffaroArmando Rossello
© 2021 Meta ULC. All rights reserved